Farms.com Home   News

Grain Markets Watch For USDA June 10 Reports.

The USDA’s June 10 reports will be closely watched by the grain trade.  The big question remains - "Where are grain prices headed this summer?"

The market will be watching the supply and demand numbers for soybeans.  Robust soybean demand and questions about South American production has driven futures prices higher the past few weeks to two year highs.

The soybean price rally has several factors moving it higher including the influx of managed money and the weather.

Losses from flooding in Argentina began to turn sales of soybeans and soybean meal back to the U.S., tightening projections for both old and new crop supplies. Business does appear to be picking up a little, and USDA could knock another 15 to 20 million bushels off its forecast for old crop carryout on June 10. But with harvest of some of the hardest-hit areas in Argentina only beginning, the government isn’t likely to change its projections much until more is known about the extent of damage.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.